<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00215878</url>
  </required_header>
  <id_info>
    <org_study_id>Heresco2CTIL</org_study_id>
    <secondary_id>20030311</secondary_id>
    <nct_id>NCT00215878</nct_id>
  </id_info>
  <brief_title>D-serine for Posttraumatic Stress Disorder Treatment</brief_title>
  <official_title>D-serine for Posttraumatic Stress Disorder Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Herzog Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Herzog Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to asses the effects of the NMDA receptor full agonist D-serine
      while used as adjuvant treatment for individuals suffering from chronic posttraumatic stress
      disorder (PTSD). Dysfunction of neurotransmission mediated at NMDA receptor plays a cardinal
      role in the pathophysiology of PTSD and PTSD patients typically suffer from cognitive
      dysfunctions and avoidance&amp; depressive symptomatology that may be mediated by NMDA receptor
      function deficits.

      Thus, enhancement of NMDA activity by using D-serine may be beneficial in the treatment of
      PTSD. The study design involves two 6 week periods during which the participants will be
      randomly assigned to receive treatment with D-serine (~2g /dy)and placebo. This design allows
      each participant the opportunity to respond to the experimental treatment.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2003</start_date>
  <completion_date type="Actual">May 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CAPS scores</measure>
    <time_frame>6 week treatment</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Posttraumatic Stress Disorder</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Adjuvant 6 weeks treatment with placebo (~2g /day)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adjuvant 6 weeks treatment with D-serine (~2g /day)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>D-serine (~2g /day)</intervention_name>
    <description>Two 6 weeks treatment arms under a cross over design. In one arm adjuvant treatment with experimental medication (D-serine ~2g /day), in the second arm adjuvant treatment with placebo (~2g /day)</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        â€¢ Chronic PTSD (DSM-IV diagnosis)

        Exclusion Criteria:

          -  Other psychiatric diagnosis

          -  Substance abuse

          -  Unstable medical condition
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Uriel Heresco-Levy, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ezrat Nashim-Herzog Memorial Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ezrat Nashim-Herzog Memorial Hospital</name>
      <address>
        <city>Jerusalem</city>
        <zip>91351</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>July 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 18, 2005</study_first_submitted>
  <study_first_submitted_qc>September 18, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2005</study_first_posted>
  <last_update_submitted>July 5, 2012</last_update_submitted>
  <last_update_submitted_qc>July 5, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 9, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Herzog Hospital</investigator_affiliation>
    <investigator_full_name>Heresco-Levi Uriel</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

